Research
We aim to integrate longitudinal patient data, cutting-edge multi-omics technologies, and novel computational approaches to monitor individual disease progression and dissect the underlying disease-driving mechanisms. In particular, we are interested in the roles of immune cells (macrophages, monocytes, dendritic cells, etc.) and RNA splicing-centric transcriptional regulation in disease progression.
Currently, we focus on obesity and its associated metabolic diseases, especially non-alcoholic fatty liver disease and diabetes.